探索大麻的抗阿尔茨海默症潜力:包括分子对接,分子动力学和ADMET评估在内的广泛计算研究
Hassan Nour1, Imane Yamari1, Oussama Abchir1
1Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Morocco.
Medicinal chemistry (Shariqah (United Arab Emirates))
|June 17, 2025
概括
大麻化合物四化甘和Δ-9-四化甘醇显示出对阿尔茨海默病的胆酶抑制剂的潜力. 计算研究预测了这些植物成分的有利结合,安全性和大脑透.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
背景情况:
- 胆酶酶对神经传递至关重要,其抑制是控制阿尔茨海默病症状的关键策略.
- 胆酶对乙胆的水解对记忆和认知至关重要.
研究的目的:
- 使用计算方法,从Cannabis sativa L.中识别潜在的胆酶抑制剂.
- 评估植物成分是否有抑制胆化酶酶的能力,用于阿尔茨海默氏症治疗.
主要方法:
- 使用分子对接,对来自Cannabis sativa L.的49种植物成分进行了in silico选.
- 选择化合物的药理动力学和药理毒理学分析 (ADMET).
- 分子动力学模拟以评估联结蛋白复合体的稳定性.
主要成果:
- 甲基卡纳比瓦林和Δ-9-甲基卡纳比诺尔对胆酶酶表现出强烈的结合亲和力,超过了Rivastigmine和Galantamine等现有的药物.
- 根据ADMET的预测,这些大麻素适合口服,无变异性,无肝毒性和无敏感性.
- 模拟证实了血脑屏障的透性和稳定的复合体形成,表明中枢神经系统的治疗潜力.
结论:
- 这项研究确定了针对阿尔茨海默病的有希望的基于大麻素的胆酶抑制剂.
- 这些发现为新型抗阿尔茨海默氏症治疗药物的制药开发提供了战略方向.
更多相关视频
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
27.1K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.3K
相关概念视频
01:26Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
343
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
343